Study in Patients' With Persistent Asthma and Chronic Obstructive Pulmonary Disease

Inclusion Criteria

• •Patient ≥ 18 years of age who has been diagnosed with persistent asthma or patient ≥ 40 years of age and/or (ex)-smoker with more than 10 pack years of smoking who has been diagnosed with COPD
• •Treatment with a stable dose (no change in dose or change by less than 50% in the last 3 months) of a Inhaled corticosteroid (ICS), Long-acting beta2-agonists (LABA), Fixed dose combination (FDC) administered twice daily by Dry powder inhaler (DPI) for 3 months prior to enrollment in accordance with its approved indication
• •Patient is willing and able to provide written informed consent;
• •Patient agrees to participate in the study and to disclose any medical events to the treating physician;
• •Patient is able to complete the questionnaires.